Evidence map›Paper›PMID 40229899›Full record

ArticleGenome medicine2025

Bi-allelic variants in BRF2 are associated with perinatal death and craniofacial anomalies.

Francesca Mattioli, Rún Friðriksdóttir, Anne Hebert, Sissy Bassani, Nazia Ibrahim, Shagufta Naz, Jacqueline Chrast, Clara Pailler-Pradeau, Ásmundur Oddsson, Patrick Sulem and 13 more

Abstract read
In one paragraph

Article in Genome medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Francesca Mattioli *Center for Integrative Genomics, University of Lausanne, Genopode Building, CH-1015, Lausanne, Switzerland.
Rún Friðriksdóttir *deCODE Genetics/Amgen Inc, Reykjavik, Iceland.
Anne Hebert *Center for Integrative Genomics, University of Lausanne, Genopode Building, CH-1015, Lausanne, Switzerland.
Sissy Bassani *Center for Integrative Genomics, University of Lausanne, Genopode Building, CH-1015, Lausanne, Switzerland.
Nazia IbrahimCenter for Integrative Genomics, University of Lausanne, Genopode Building, CH-1015, Lausanne, Switzerland.
Shagufta NazLahore College for Women University, Lahore, Pakistan.
Jacqueline ChrastCenter for Integrative Genomics, University of Lausanne, Genopode Building, CH-1015, Lausanne, Switzerland.
Clara Pailler-PradeauCenter for Integrative Genomics, University of Lausanne, Genopode Building, CH-1015, Lausanne, Switzerland.
Ásmundur OddssondeCODE Genetics/Amgen Inc, Reykjavik, Iceland.
Patrick SulemdeCODE Genetics/Amgen Inc, Reykjavik, Iceland.
Gisli H HalldorssondeCODE Genetics/Amgen Inc, Reykjavik, Iceland.
Páll MelsteddeCODE Genetics/Amgen Inc, Reykjavik, Iceland.
Daníel F GuðbjartssondeCODE Genetics/Amgen Inc, Reykjavik, Iceland.
Flavia PalomboIRCCS Istituto Delle Scienze Neurologiche, Programma Di Neurogenetica, Bologna, Italy.
Tommaso PippucciIRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
Nayereh NouriCraniofacial and Cleft Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Marco SeriIRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
Emily G FarrowUniversity of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
Carol J SaundersUniversity of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
Nicolas GuexBioinformatics Competence Center, University of Lausanne, Lausanne, Switzerland.
Muhammad AnsarDepartment of Ophthalmology, University of Lausanne, Jules-Gonin Eye Hospital, Fondation Asile Des Aveugles, Lausanne, Switzerland.
Kari StefanssondeCODE Genetics/Amgen Inc, Reykjavik, Iceland.
Alexandre ReymondCenter for Integrative Genomics, University of Lausanne, Genopode Building, CH-1015, Lausanne, Switzerland. alexandre.reymond@unil.ch.

Funding

Fondation Jérôme Lejeune 18382019AHigher Education Commision, Pakistan 1-8/HEC/HRD/2020/10867Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 31003A_182632Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung IZSTZ0_216615
6 · The paper itself

Abstract

backgroundVariants in genes encoding multiple subunits of the RNA Polymerase III complex which synthesizes rRNAs, tRNAs, and other small RNAs were previously associated with neurological disorders, such as syndromic hypomyelination leukodystrophies, pontocerebellar hypoplasia, and cerebellofaciodental syndrome. One new such candidate is BRF2, which encodes a TFIIB-like factor that recruits the RNA polymerase III complex to type 3 promoters to initiate transcription of U6, RnaseP, and 7SK RNAs.

methodsWe combined sequencing with functional analyses to investigate the effects of BRF2 variants.

resultsWe observe that a previously reported significant underrepresentation of double transmission of a splice variant results in recessive lethality in three large Icelandic families with multiple perinatal losses. Using data aggregation, we identified an additional seven individuals worldwide from three unrelated families carrying biallelic variants in BRF2. Affected individuals present a variable phenotype ranging from severe craniofacial anomalies with early death to intellectual disability with motor and speech development. In silico 3D modelling and functional analyses showed functional impairment of the identified variants, e.g., differences in target loci occupancy. Zebrafish knocked down for the orthologous brf2 presented with abnormal escape response, reduced swimming velocity and head size, and craniofacial malformations. These defects were complemented by the human wild-type but not mutated BRF2 mRNA further demonstrating their deleteriousness.

conclusionsOverall, our results support the association of biallelic BRF2 variants with a novel neurodevelopmental disease and provide an additional link between RNA polymerase III, its targets and craniofacial anomalies.

Indexed as

AllelesCraniofacial AbnormalitiesPerinatal DeathAnimalsFemaleHumansMaleMutationPedigreePhenotypeZebrafishAutosomal recessiveBRF2Craniofacial anomaliesRNA polymerase III

Identifiers

PMID40229899
PMCPMC11995667

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.